November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Low-level laser evidence inconclusive
October 1st 2004Dallas - Patients' interest in minimally invasive treatments could bode well for the future of low-level laser therapy (LLLT) in the United States, but only if its efficacy can be proven. And current research results are inconclusive, says Murad Alam, M.D., chief, section of cutaneous and aesthetic surgery, department of dermatology, Northwestern University.
Low-level laser tx promotes healing
October 1st 2004National report - Low-level laser therapy (LLLT) effectively promotes wound healing without causing burn to adjacent tissue, according Lars Hode, D.Sc. The operative principle, known as photobiomodulation, is particularly useful in treating decubitus ulcers, typical of people with diabetes and frail elderly patients who spend long hours in bed. It also has cosmetic applications and can be used for scar revision, as in the treatment of acne scars.
Scientists re-evaluate marrow/skin relationship
October 1st 2004National report-- The contribution of bone marrow-derived cells in responding to acute injury to the skin has long been known, but the focus on inflammatory markers has resulted in a skewed sense of the marrow's total contribution to the skin niche, says Frank Isik, M.D., a researcher and professor of plastic surgery at the University of Washington. New tools that allow scientists to better track the movement of cells from bone marrow to the periphery are leading to a reevaluation of the marrow/skin relationship, he says.
Target four-to-eight-week tx window to minimize formation of scar tissue
October 1st 2004To minimize scar formation, intercept facial wounds as early as possible, and treat them during the four-to-eight-week window after the trauma or incision, advises Joseph Niamtu III, D.M.D., an oral/maxillofacial and cosmetic facial surgeon based in Richmond, Va.
Combination therapies do battle with ethnic pigmentary problems
September 1st 2004New York and Pennsville, N.J. - While hydroquinone remains crucial for treating pigmentary disorders in ethnic patients, the most effective treatments frequently combine this drug with other preparations and treatment modalities.
Derms have range of tools to fade freckles
September 1st 2004National Report - Freckle-faced patients - whether they have one bothersome lentigo or a face full of mottling - have many options when it comes to achieving clearer, more even-toned skin. Depending on a patient's perceived concern, dermatologists have at their disposal therapies ranging from topical treatments to more aggressive lasers and light sources to combinations of both.
Combination strategies hasten, enhance clearing of solar lentigines
September 1st 2004National Report - Combination therapy, featuring a newer dual-agent topical solution containing mequinol 2 percent and tretinoin 0.01 percent (Solag?,Galderma) used alone but particularly together with laser or intense pulsed light (IPL) treatment, provides an improved approach for treating solar lentigines, agree Marta I. Rendon, M.D., and Fran E. Cook-Bolden, M.D.
PDA vision quickly becoming reality
September 1st 2004The recently organized Pigmentary Disorders Academy (PDA) already can be credited with a number of significant accomplishments. These accomplishments exemplify its aims to increase awareness of pigmentary disorders within the medical community and to update and educate physicians about these conditions and their treatments to enhance patient care.
Multimodal regimen provides rational, effective tratement for acne in skin of color
September 1st 2004New York - A combination regimen beginning with adapalene cream 0.1 percent (Differin, Galderma) and incorporating the fixed triple-combination depigmenting cream (Tri-Luma Cream, Galderma) provides a well-tolerated and effective method for treating acne and its distressing sequel of post-in-flammatory hyperpigmentation (PIH) in African-American patients, said Valerie D. Callender, M.D., at the recently held Academy '04 meeting of the American Academy of Dermatology.
Botulinum toxin long-term safety study finds 'no news is good news'
September 1st 2004New York - Results of a retrospective review reinforce the long-term safety and tolerability of repeated treatments with botulinum toxin type A (Botox Cosmetic?, Allergan) for cosmetic reasons, said Alastair Carruthers, M.D., at the American Academy of Dermatology's Academy '04 here recently.